A Crossover Bioequivalence Study of Intravenously Administered ATI0918 and DOXIL/CAELYX in Patients With Ovarian Cancer

Clinical trial NCT01715168 · UNKNOWN

Trial details

NCT number: NCT01715168
Sponsor: Azaya Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Ovarian Cancer Malignant Female Reproductive System Neoplasm Cancer Ovarian Tumor Ovarian Epithelial Cancer Recurrent

Start date: 2012-10-01
Primary completion: 2015-10-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.